Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection

Gabriel Chodick*, Amir Nutman, Naama Yiekutiel, Varda Shalev

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

17 Scopus citations
Original languageEnglish
Article numbertaaa069
JournalJournal of Travel Medicine
Volume27
Issue number5
DOIs
StatePublished - 2021

Keywords

  • ACE2 receptor
  • Anti-hypertensive
  • BMI
  • Body mass index
  • Covid19
  • Hypertension
  • Israel
  • Obesity
  • Vitamin D

Cite this